📰 Tissuecypher Barrett News
Tissuecypher Barrett News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tissuecypher Barrett. Real-time updates on events, politics, business and more.
February 29, 2024
Operator: Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2023 Conference Call. As a reminder, todays call is being recorded.
November 3, 2023
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Nov 2, 2023--
November 2, 2023
Q3 2023 revenue increased 66% over Q3 2022 to $61 million Q3 2023 total test reports increased 52% over Q3 2022 Raising full year 2023 revenue guidance to at least $200 million from at least $180...
September 14, 2023
The study, published in Gastroenterology, shows TissueCypher can increase the detection of Barrett’s esophagus patients with an initial diagnosis of low-grade dysplasia who will progress to...
August 7, 2023
In the study, management decisions were simulated to determine the most likely care plan with or without use of the TissueCypher test for guidance Study data shows TissueCypher test results...
August 3, 2023
Despite recent reimbursement struggles, the company said it was raising its full year guidance above its previously estimated $170 million to $180 million.
August 3, 2023
The genetic-testing company beat expectations with its Q2 results.
May 26, 2023
New data demonstrate the risk-stratification performance and potential of the TissueCypher® Barrett’s Esophagus test to guide risk-aligned patient care decisions ... | May 26, 2023
April 20, 2023
Data from patient simulation study to be presented at ESGE Days 2023 ... | April 20, 2023